Table of contents

Extended reports

• Expression of transforming growth factor-β (TGFβ) and the TGFβ signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation (26 January, 2006)

  E N Blaney Davidson, E L Vitters, P M van der Kraan, W B van den Berg
• Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero (27 February, 2006)

  A Brucato, M G Astori, R Cimaz, P Villa, M Li Destri, L Chimini, R Vaccari, M Muscarà, M Motta, A Tincani, F Neri, S Martinelli
• A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients (17 May, 2006)

  L Federici, C Rittore-Domingo, I Koné-Paut, C Jorgensen, M Rodière, A Le Quellec, I Touitou
• Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab (27 February, 2006)

  E Filippucci, A Iagnocco, F Salaffi, A Cerioni, G Valesini, W Grassi
• Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis (27 April, 2006)

  M Cutolo, C M Montecucco, L Cavagna, R Caporali, S Capellino, P Montagna, L Fazzuoli, B Villaggio, B Seriolo, A Sulli
• Reduction of leucocyte telomere length in radiographic hand osteoarthritis: a population-based study (12 October, 2006)

  G Zhai, A Aviv, D J Hunter, D J Hart, J P Gardner, M Kimura, X Lu, A M Valdes, T D Spector
• Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis (15 March, 2006)

  S L Hider, A Silman, D Bunn, S Manning, D Symmons, M Lunt
• Long-term outcome in polymyositis and dermatomyositis (10 April, 2006)

  I M Bronner, M F G van der Meulen, M de Visser, S Kalmijn, W J van Venrooij, A E Voskuyl, H J Dinant, W H J P Linssen, J H J Wokke, J E Hoogendijk
• Mannan-binding lectin and complement C4A in Icelandic multicase families with systemic lupus erythematosus (26 January, 2006)

  S Saevarsdottir, H Kristjansdottir, G Grondal, T Vikingsdottir, K Steinsson, H Valdimarsson
• Annexin A5 polymorphism (−1C→T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome (31 January, 2006)

  B de Laat, R H W M Derksen, I J Mackie, M Roest, S Schoormans, B J Woodhams, P G de Groot, W L van Heerde
• Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis (27 April, 2006)

  V P van Halm, J C van Denderen, M J L Peters, J W R Twisk, M van der Paardt, I E van der Horst-Bruinsma, R J van de Stadt, M H M T de Koning, B A C Dijkmans, M T Nurmohamed
• Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study (7 February, 2006)

  P L C M van Riel, A J Taggart, J Sany, M Gaubitz, H W Nab, R Pedersen, B Freundlich, D MacPeek
• Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse (27 February, 2006)

  J-S F Sanders, M G Huitma, C G M Kallenberg, C A Stegeman
• Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis (17 May, 2006)

  M L E Andersson, I F Petersson, K E Karlsson, E N Jonsson, B Månsson, D Heinegård, T Saxne
• Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis (10 April, 2006)

  M Vis, E A Havaardsholm, G Haugeberg, T Uhlig, A E Voskuyl, R J van de Stadt, B A C Dijkmans, A D Woolf, T K Kvien, W F Lems
• Ethnicity and mortality from systemic lupus erythematosus in the US (20 April, 2006)

  E Krishnan, H B Hubert
• Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy (5 May, 2006)

  S M M Verstappen, J N Hoes, E J ter Borg, J W J Bijlsma, A A M Blaauw, G A van Albada-Kuipers, C van Booma-Frankfort, J W G Jacobs
• Enrichment of CD4+ CD25^high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids

  (10 April, 2006)

  A Suárez, P López, J Gómez, C Gutiérrez